Actavis plc (NYSE: ACT) and Allergan, Inc. (NYSE: AGN) today announced
that the U.S. Federal Trade Commission (FTC) has granted early
termination of the waiting period under the Hart-Scott-Rodino Antitrust
Improvements Act of 1976 (HSR Act) with respect to Actavis’ pending
acquisition of Allergan.
for Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis’ Pending Acquisition of Allergan and Record Dates for Shareholder Meetings investment picks